Invesco’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.01M | Sell |
118,744
-3,331
| -3% | -$28.2K | ﹤0.01% | 2841 |
|
|
2025
Q1 | $981K | Sell |
122,075
-22,037
| -15% | -$177K | ﹤0.01% | 2828 |
|
|
2024
Q4 | $1.29M | Buy |
144,112
+1,421
| +1% | +$12.8K | ﹤0.01% | 2795 |
|
|
2024
Q3 | $1.05M | Sell |
142,691
-977
| -0.7% | -$7.16K | ﹤0.01% | 2877 |
|
|
2024
Q2 | $820K | Buy |
143,668
+2,613
| +2% | +$14.9K | ﹤0.01% | 3029 |
|
|
2024
Q1 | $707K | Sell |
141,055
-3,634
| -3% | -$18.2K | ﹤0.01% | 3153 |
|
|
2023
Q4 | $1.3M | Buy |
144,689
+9,751
| +7% | +$87.7K | ﹤0.01% | 2773 |
|
|
2023
Q3 | $1.05M | Buy |
134,938
+8,511
| +7% | +$66.1K | ﹤0.01% | 2830 |
|
|
2023
Q2 | $1.22M | Sell |
126,427
-284
| -0.2% | -$2.75K | ﹤0.01% | 2803 |
|
|
2023
Q1 | $1.39M | Buy |
126,711
+44,128
| +53% | +$484K | ﹤0.01% | 2768 |
|
|
2022
Q4 | $357K | Sell |
82,583
-5,868
| -7% | -$25.4K | ﹤0.01% | 3416 |
|
|
2022
Q3 | $665K | Buy |
88,451
+1,985
| +2% | +$14.9K | ﹤0.01% | 3075 |
|
|
2022
Q2 | $868K | Buy |
86,466
+53,715
| +164% | +$539K | ﹤0.01% | 3028 |
|
|
2022
Q1 | $405K | Buy |
32,751
+21,340
| +187% | +$264K | ﹤0.01% | 3464 |
|
|
2021
Q4 | $261K | Sell |
11,411
-3,218
| -22% | -$73.6K | ﹤0.01% | 3635 |
|
|
2021
Q3 | $324K | Sell |
14,629
-3,342
| -19% | -$74K | ﹤0.01% | 3594 |
|
|
2021
Q2 | $233K | Buy |
+17,971
| New | +$233K | ﹤0.01% | 3705 |
|
|
2018
Q1 | – | Sell |
-10,578
| Closed | -$48K | – | 3695 |
|
|
2017
Q4 | $48K | Buy |
+10,578
| New | +$48K | ﹤0.01% | 3621 |
|